BEIJING, Dec. 22 -- A total of 117 new medicines developed by Chinese researchers have been certified thanks to support from a major national project, a health official said Saturday.
Yu Jingjin, in charge of pharmaceutical policies at the National Health Commission, said this means Chinese researchers' focus is rapidly shifting from making generic drugs to making original ones.
Launched in 2008, the national project aims to develop or modify medicines for 10 critical diseases, including malignant tumors.
As of the end of October 2018, the project had spent over 19 billion yuan (around 2.76 billion U.S. dollars) from central finance, Yu said.
About 170 medicines from enterprises supported by the project are now registered and on sale in the U.S., while nearly 100 new medicines are currently in the clinical trial phase, according to Yu.
In addition, four vaccines and 21 chemical preparations have been preapproved by the World Health Organization, meaning the organization recognizes their safety and effectiveness, he said.
My Ideal Job 我理想的工作
工作狂要小心:压力太大会导致一夜白头!
邓文迪离婚与布莱尔有关?英国前首相声明否认
又是一年毕业季:10大最佳毕业典礼演讲
国内英语资讯:China honors outstanding builders of socialism with Chinese characteristics
体坛英语资讯:Man City beat Liverpool on penalties to lift Community Shield
国内英语资讯:China, the Philippines set up joint steering committee on oil, gas cooperation
对付“咸猪手”有新招 日本“防狼印章”半小时售罄
上海电影节开幕众星云集
体坛英语资讯:Santos stretch lead in Brazils Serie A